Notes - Segment Information, Etc.

Carna Biosciences, Inc. - Filing #7613644

Concept 2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Notes - Segment information, etc.
Segment information
Disclosure of sales, profit (loss), asset, liability, and other items for each reportable segment
Sales
Revenues from external customers
1,128,000,000 JPY
2,017,529,000 JPY
JPY
889,529,000 JPY
2,017,529,000 JPY
JPY
1,080,321,000 JPY
1,133,346,000 JPY
1,133,346,000 JPY
53,025,000 JPY
Transactions with other segments
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Other items
Depreciation
4,510,000 JPY
19,164,000 JPY
JPY
14,653,000 JPY
19,164,000 JPY
JPY
7,223,000 JPY
12,410,000 JPY
12,410,000 JPY
5,186,000 JPY
Increase in property, plant and equipment and intangible assets
13,765,000 JPY
25,872,000 JPY
JPY
12,107,000 JPY
25,872,000 JPY
JPY
33,915,000 JPY
65,767,000 JPY
65,767,000 JPY
31,851,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.